Sofinnova Investments’s Travere Therapeutics TVTX Stock Holding History

Sofinnova Investments’s Portfolio TVTX Stock Details TVTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$568K	Buy
2023 Q2	–	Sell
2023 Q1	$28.4M	Buy
2022 Q4	$12.2M	Buy
2022 Q3	$9.72M	Buy
2022 Q2	$5.15M	Sell
2022 Q1	$17M	Sell
2021 Q4	$32.3M	Buy
2021 Q3	$10.6M	Buy